Prognosis evaluation and efficacy analysis of different treatment options for patients with visceral pleural invasion in stage IIA–IIB lung cancer
In patients with visceral pleural invasion of stage IIA-IIB lung cancer, chemotherapy has shown a significant effect on improving prognosis and enhancing efficacy. However, surgical treatment did not significantly improve the overall prognosis. Therefore, the individual situation of the patient and the comprehensive benefits of the treatment program should be fully considered when developing the treatment program.
Authors
- Liusheng Wu (ORCID: https://orcid.org/0000-0001-9580-2257)
- Yuchen Feng (ORCID: https://orcid.org/0000-0001-5507-8129)
- Jun Yan (ORCID: https://orcid.org/0000-0002-6474-1049)
- Xiaoqiang Li (ORCID: https://orcid.org/0000-0002-9692-1458)
- Ying Wang (ORCID: https://orcid.org/0000-0002-1340-8422)
- Qi Liu (ORCID: https://orcid.org/0000-0001-6412-3286)
- Xiangyu Wang (ORCID: https://orcid.org/0009-0007-8186-3017)
Institutions
- National University of Singapore (SG)
- Zunyi Medical University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Peking University Shenzhen Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1007/s12672-024-01307-3
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Tsinghua University
- China Scholarship Council